Global Transurethral Prostatic Resection Device Market Strategic Research Report

Scope of the Report

The global Transurethral Prostatic Resection Device market size is predicted to grow from US$ 1,383 million in 2025 to US$ 1,984 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.

A transurethral resection of the prostate (TURP) is a surgical procedure that involves cutting away a section of the prostate. The prostate is a small gland in the pelvis only found in men. It"s located between the penis and bladder, and surrounds the urethra (the tube that carries urine from the bladder to the penis).

The global transurethral prostatic resection device market refers to the industry that provides medical devices used in transurethral resection of the prostate (TURP) procedures. TURP is a minimally invasive surgical procedure performed to treat benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland. Here’s an overview of the market:

Market Overview: The transurethral prostatic resection device market has witnessed significant growth due to the increasing prevalence of BPH and the rising demand for minimally invasive treatment options. TURP is a widely accepted and effective procedure for relieving urinary symptoms associated with BPH, and the demand for TURP devices is driven by the growing patient population and advancements in technology.

Procedure and Device: TURP involves the removal of excess prostate tissue using a resectoscope, which is a specialized instrument inserted through the urethra. The resectoscope typically consists of a sheath, a working element with an electrode, and an irrigation system. During the procedure, the resectoscope allows the surgeon to remove the obstructing prostate tissue and cauterize bleeding vessels.

Types of TURP Devices: The market offers a variety of TURP devices, including monopolar and bipolar resectoscopes. Monopolar resectoscopes use an electrical current to cut and cauterize tissue, while bipolar resectoscopes pass the electrical current through the saline irrigation fluid, reducing the risk of complications associated with monopolar devices. Other types of TURP devices may include continuous flow resectoscopes and laser resectoscopes, which offer alternative methods for performing the procedure.

Market Players: The market for transurethral prostatic resection devices is competitive and comprises various medical device manufacturers. Key market players may include leading medical technology companies and specialized manufacturers that provide a range of TURP devices. These companies focus on product innovation, safety, and efficiency to meet the needs of healthcare professionals performing TURP procedures.

Market Dynamics: The market is driven by factors such as the increasing prevalence of BPH, technological advancements in TURP devices, a growing elderly population, and the demand for minimally invasive procedures. Additionally, rising awareness about the benefits of TURP over traditional open surgeries, such as shorter hospital stays and faster recovery, contributes to the market growth.

Regional Markets: The global transurethral prostatic resection device market is segmented into various regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe have a significant market share due to the high prevalence of BPH and the availability of advanced healthcare facilities. The market in Asia Pacific is expected to witness substantial growth due to the increasing aging population and improving healthcare infrastructure in the region.

Regulatory Landscape: The transurethral prostatic resection device market is subject to various regulatory and quality standards set by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must comply with these regulations to ensure the safety and effectiveness of their devices.

Market Outlook: The global transurethral prostatic resection device market is projected to grow in the coming years, driven by the increasing prevalence of BPH, advancements in TURP technology, and the growing adoption of minimally invasive procedures. However, factors such as the availability of alternative treatment options and the high cost of TURP devices may pose challenges to market growth.

This report presents a comprehensive overview of the global Transurethral Prostatic Resection Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Monopolar TURP
• Bipolar TURP

Segment by Application

• Benign Prostate Hyperplasia
• Urinary Tract Infection
• Erectile Dysfunction
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Transurethral Prostatic Resection Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Benign Prostate Hyperplasia, Urinary Tract Infection, Erectile Dysfunction evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact